Skip to main navigation Skip to search Skip to main content

Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage

  • Peter Ochodnicky
  • , Robert H. Henning
  • , Richard P. E. van Dokkum
  • , Dick de Zeeuw
  • University of Groningen, University Medical Center Groningen

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

A minor increase in urinary albumin excretion (microalbuminuria) is known to predict adverse renal and cardiovascular events in diabetic and hypertensive patients. Recent intriguing findings show that microalbuminuria is an early and sensitive marker of future cardiovascular events even in healthy subjects. The mechanisms linking microalbuminuria with end-organ damage have not been fully explained yet; however, generalized endothelial dysfunction might play an important role. Prevailing experimental and clinical data suggest that generalized endothelial dysfunction, frequently characterized by decreased nitric oxide bioavailability, actually precedes the development of microalbuminuria. This review summarizes the current knowledge about the intricate relationship between microalbuminuria and endothelial dysfunction. On the basis of the current evidence, we propose that microalbuminuria and endothelial dysfunction are an emerging target for primary prevention strategies in cardiovascular disease. In near future, dietary components improving nitric oxide bioavailability, such as cocoa-derived flavanols may play important role in these preventive strategies. © 2006 Lippincott Williams & Wilkins, Inc.
Original languageEnglish
JournalJournal of cardiovascular pharmacology
Volume47
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Jun 2006
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage'. Together they form a unique fingerprint.

Cite this